Procarbazine [prokarbazin]
- Terms
-
hydrochlorid prokarbazinu
prokarbazin-hydrochlorid
prokarbazin-monohydrobromid
-
Matulane
Natulan
Procarbazine Hydrochloride
Procarbazine Monohydrobromide
Procarbazine Monohydrochloride
An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
- DUI
- D011344 MeSH Browser
- CUI
- M0017616
- CAS
- Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)-
- Previous indexing
- Benzoates (1966-1970); Antineoplastic Agents (1966-1970)
- History note
- 74(71)
- Public note
- 74
Allowable subheadings
- AD
- administration & dosage 11
- AE
- adverse effects 3
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 3
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 14
- TO
- toxicity 3
- UR
- urine